Breast Cancer Research and Treatment

, Volume 129, Issue 2, pp 593–606

Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes

Authors

    • Department of EpidemiologyUniversity of North Carolina
    • Lineberger Comprehensive Cancer CenterUniversity of North Carolina
    • Division of Cancer Epidemiology and GeneticsNational Cancer Institute
  • Marilie D. Gammon
    • Department of EpidemiologyUniversity of North Carolina
    • Lineberger Comprehensive Cancer CenterUniversity of North Carolina
  • Jay S. Kaufman
    • Department of Epidemiology, Biostatistics, & Occupational HealthMcGill University
  • Jeannette T. Bensen
    • Department of EpidemiologyUniversity of North Carolina
    • Lineberger Comprehensive Cancer CenterUniversity of North Carolina
  • Dan Yu Lin
    • Lineberger Comprehensive Cancer CenterUniversity of North Carolina
    • Department of BiostatisticsUniversity of North Carolina
  • Jill S. Barnholtz-Sloan
    • Case Comprehensive Cancer CenterCase Western Reserve University School of Medicine
  • Yijuan Hu
    • Department of BiostatisticsUniversity of North Carolina
  • Qianchuan He
    • Department of BiostatisticsUniversity of North Carolina
  • Jingchun Luo
    • Lineberger Comprehensive Cancer CenterUniversity of North Carolina
  • Robert C. Millikan
    • Department of EpidemiologyUniversity of North Carolina
    • Lineberger Comprehensive Cancer CenterUniversity of North Carolina
Epidemiology

DOI: 10.1007/s10549-011-1517-z

Cite this article as:
Nyante, S.J., Gammon, M.D., Kaufman, J.S. et al. Breast Cancer Res Treat (2011) 129: 593. doi:10.1007/s10549-011-1517-z

Abstract

Adipocytokines are produced by visceral fat, and levels may be associated with breast cancer risk. We investigated whether single nucleotide polymorphisms (SNPs) in adipocytokine genes adiponectin (ADIPOQ), leptin (LEP), and the leptin receptor (LEPR) were associated with basal-like or luminal A breast cancer subtypes. 104 candidate and tag SNPs were genotyped in 1776 of 2022 controls and 1972 (200 basal-like, 679 luminal A) of 2311 cases from the Carolina Breast Cancer Study (CBCS), a population-based case–control study of whites and African Americans. Breast cancer molecular subtypes were determined by immunohistochemistry. Genotype odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression. Haplotype ORs and 95% CIs were estimated using Hapstat. Interactions with waist-hip ratio were evaluated using a multiplicative interaction term. Ancestry was estimated from 144 ancestry informative markers (AIMs), and included in models to control for population stratification. Candidate SNPs LEPR K109R (rs1137100) and LEPR Q223R (rs1137101) were positively associated with luminal A breast cancer, whereas ADIPOQ +45 T/G (rs2241766), ADIPOQ +276 G/T (rs1501299), and LEPR K656N (rs8129183) were not associated with either subtype. Few patterns were observed among tag SNPs, with the exception of 3 LEPR SNPs (rs17412175, rs9436746, and rs9436748) that were in moderate LD and inversely associated with basal-like breast cancer. However, no SNP associations were statistically significant after adjustment for multiple comparisons. Haplotypes in LEP and LEPR were associated with both basal-like and luminal A subtypes. There was no evidence of interaction with waist-hip ratio. Data suggest associations between LEPR candidate SNPs and luminal A breast cancer in the CBCS and LEPR intron 2 tag SNPs and basal-like breast cancer. Replication in additional studies where breast cancer subtypes have been defined is necessary to confirm these potential associations.

Keywords

AdiponectinLeptinLeptin receptorBreast cancerSubtypesSingle nucleotide polymorphism

Supplementary material

10549_2011_1517_MOESM1_ESM.doc (482 kb)
Supplementary material 1 (DOC 482 kb)

Copyright information

© Springer Science+Business Media, LLC. 2011